|
[1]
|
The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events
The Pharmacogenomics Journal,
2024
DOI:10.1038/s41397-024-00323-4
|
|
|
|
|
[2]
|
The Effect of Chronic Immunosuppressive Regimen Treatment on Apoptosis in the Heart of Rats
Pharmaceuticals,
2024
DOI:10.3390/ph17091188
|
|
|
|
|
[3]
|
Peculiarities of the induction immunosuppressive therapy in renal transplantation
Klinicheskaia khirurgiia,
2022
DOI:10.26779/2522-1396.2022.11-12.46
|
|
|
|
|
[4]
|
Posttransplantation tuberculosis management in terms of immunosuppressant cost: a case report in Myanmar
Korean Journal of Transplantation,
2021
DOI:10.4285/kjt.20.0041
|
|
|
|
|
[5]
|
Exploring the safety and efficacy of adding ketoconazole to tacrolimus in pediatric renal transplant immunosuppression
World Journal of Transplantation,
2020
DOI:10.5500/wjt.v10.i11.356
|
|
|
|
|
[6]
|
Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
BMC Nephrology,
2019
DOI:10.1186/s12882-019-1293-2
|
|
|
|
|
[7]
|
Medical Pharmacology and Therapeutics
2018
DOI:10.1016/B978-0-7020-7167-6.00038-5
|
|
|
|
|
[8]
|
Clinical Management of Kidney Allograft Dysfunction
Open Journal of Organ Transplant Surgery,
2014
DOI:10.4236/ojots.2014.42002
|
|
|
|